ACTR-19. A PHASE 2 STUDY OF TUMOR TREATING FIELDS AND BEVACIZUMAB IN RECURRENT OR PROGRESSIVE MENINGIOMA

Meningioma is the most common primary brain tumor with a prevalence of ~170,000 in the United States. For patients with WHO grade II meningioma, the two- and five-year overall survival was 93% and 73%, respectively. Patients with malignant meningioma (grade III) had significantly worse outcomes, wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Kumthekar, Priya, Kruser, Timothy, Sachdev, Sean, Raizer, Jeffrey, Grimm, Sean, Dixit, Karan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692851/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller